Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Not Yet Recruiting

Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.

NCT06720701

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Not Yet Recruiting

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

NCT06721598

Conditions: Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: National Medical Research Center for Hematology Moscow, Russia

View Trial Details

Not Yet Recruiting

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

NCT06646211

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Real-World Study on Extranodal Lymphoma

NCT06573099

Conditions: Diffuse Large B Cell Lymphoma, Extranodal Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Astragalus for Symptomatic Alleviation in High-grade Lymphoma

NCT06510530

Conditions: Hemic and Lymphatic Diseases, High-grade Lymphoma, Immune System Diseases, +7 more
Locations: Bnai Zion Medical Center Haifa, Israel

View Trial Details

Not Yet Recruiting

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT06427213

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

NCT06318884

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

NCT06097455

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHU Santiago de Compostela Santiago de Compostela, A Coruña, Spain

Hospital Clínic Barcelona Barcelona, Spain

H. Ramon y Cajal Madrid, Spain

H.U. Virgen de la Arrixaca Murcia, Spain

View Trial Details

Not Yet Recruiting

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT05923502

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

NCT05834426

Conditions: Cancer, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Instituto Oncológico Nacional Dr. Juan Tanca Marengo Guayaquil, Guayas, Ecuador

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions